Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT06683677

High Flow Nasal Cannula for Stabilization of Extremely Premature Infants

High Flow Nasal Cannula is Appropriate Alternative for Stabilization of Extremely Premature Infants: a Prospective Observational Study

Status
Not Yet Recruiting
Phase
N/A
Study type
Interventional
Enrollment
60 (estimated)
Sponsor
Charles University, Czech Republic · Academic / Other
Sex
All
Age
0 Minutes – 2 Minutes
Healthy volunteers
Not accepted

Summary

A prospective observational study evaluates the safety and efficacy of using High-Flow Nasal Cannula to stabilize extremely preterm infants immediately after birth. Following placental transfusion, high flow nasal cannula at 6-8 l/min is administered along with intermittent tactile stimulation. Criteria for switching to other interventions like continuous positive airway pressure or positive pressure ventilation are set for cases of persistent bradycardia or low Saturation of oxygen (SpO2).

Conditions

Interventions

TypeNameDescription
DEVICEHigh-Flow Nasal CannulaThe intervention involves administering High-Flow Nasal Cannula therapy to extremely preterm infants immediately after birth.

Timeline

Start date
2024-12-01
Primary completion
2028-12-31
Completion
2029-07-01
First posted
2024-11-12
Last updated
2024-11-14

Locations

1 site across 1 country: Czechia

Source: ClinicalTrials.gov record NCT06683677. Inclusion in this directory is not an endorsement.